2012

1. Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: A validation phase II trial

   International Journal of Radiation Oncology Biology Physics, Vol. 83, Núm. 2, pp. 587-593